Dube Michael P 4
4 · Intellia Therapeutics, Inc. · Filed Oct 3, 2025
Insider Transaction Report
Form 4
Dube Michael P
VP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-10-01$17.38/sh−1,871$32,518→ 55,266 total
Footnotes (1)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2025, and does not represent a volitional trade by the Reporting Person.